Stock Events

Pfizer 

$27.73
19696
-$0.1-0.38% Wednesday 19:54

統計

當日最高
28.05
當日最低
27.62
52週最高
35.8
52週最低
24.83
成交量
10,580,873
平均成交量
32,277,515
市值
156.71B
市盈率
-508.36
股息收益率
6.06%
股息
1.68

即將到來

股息

6.06%股息收益率
10年增長
4.91%
5年增長率
3.13%
3年增長率
2.5%
1年增長率
2.44%

收益

1May確認
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.18
0.47
1.13
1.78
預期每股收益
0.53
實際每股收益
0.82

人們還關注

此列表基於在 Stock Events 上關注 PFE 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

36.5$平均價格目標
最高估價為 $45。
來自過去 6 個月內的 5 個評級。這不是投資建議。
買入
60%
持有
40%
賣出
0%

關於

Health Technology
Pharmaceuticals: Major
Manufacturing
Pharmaceutical Preparation Manufacturing
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Show more...
首席執行官
員工
88000
國家
US
ISIN
US7170811035
WKN
000852009

上市公司